Delta-tetrahydrocannabinol suppresses macrophage costimulation by decreasing heat-stable antigen expression

International Journal of Immunopharmacology

Volumn 20, Issue 8, 1998, Pages 415-428

  Clements, Dorothy J ^a   Matveyeva, Marina ^a   McCoy, Kathleen L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Delta9 tetrahydrocannabinol; Immunosuppression; Macrophage function; T cell costimulation

Indexed keywords

DRONABINOL; INTERLEUKIN 2; PHOSPHOLIPASE C; T LYMPHOCYTE RECEPTOR; ANTIGEN; B7 ANTIGEN; CD3 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL LYASE; TETRAHYDROCANNABINOL;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; DRUG EFFECT; FLOW CYTOMETRY; HELPER CELL; HYBRIDOMA; IMMUNE RESPONSE; MACROPHAGE FUNCTION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; BIOSYNTHESIS; HUMAN; IMMUNOLOGY; MACROPHAGE; METABOLISM; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; ANTIGENS; ANTIGENS, CD3; ANTIGENS, CD80; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MACROPHAGES; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE; PHOSPHOLIPASE C; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; TETRAHYDROCANNABINOL;

EID: 0032219490     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00044-7     Document Type: Article

References (44)

1. Altman, A., Coggeshall, K. M., & Mustelin, T. (1990). Molecular events mediating T cell activation. Adv. Immunol., 48, 227-360.
2. Baker, P. E., Gillis, S., & Smith, K. A. (1979). Monoclonal cytolytic T cell lines. J. Exp. Med., 149, 273-278.
3. Bažil, V. (1995). Physiological enzymatic cleavage of leukocyte membrane molecules. Immunol. Today, 16, 135-140.
4. Bruce, J., Symington, F. W., McKearn, T. J., & Sprent, J. (1981). A monoclonal antibody discriminating between subsets of T and B cells. J. Immunol., 127, 2496-2501.
5. Burnette-Curley, D., Marciano-Cabral, F., Fischer-Stenger, K., & Cabral, G. A. (1993). Delta-9-tetrahydrocannabinol inhibits cell contact-dependent cytotoxicity of bacillus Calmétte-Guérin-activated macrophages. Int. J. Immunopharmacol., 15, 371-382.
6. Cabral, G. A., & Fischer-Stenger, K. (1994). Inhibition of macrophage inducible protein expression by delta-9-tetrahydrocannabinol. Life Sci., 54, 1831-1844.
7. Chien, Y. H., & Davis, M. M. (1993). How alpha beta T-cell receptors 'see' peptide/MHC complexes. Immunol. Today, 14, 597-602.
8. 9-Tetrahydrocannabinol selectively inhibits macrophage costimulatory acitivity and down-regulates heat-stable antigen expression. J. Pharmacol. Exp. Ther., 277, 1315-1321.
9. Coffey, R. G., Yamamoto, Y., Snella, E., & Pross, S. (1996). Tetrahydrocannabinol inhibition of macrophage nitric oxide production. Biochem. Pharmacol., 52, 743-751.
10. De Bruijn, M. L. H., Peterson, P. A., & Jackson, M. R. (1996). Induction of heat-stable antigen expression by phagocytosis is involved in in vitro activation of unprimed CTL by macrophages. J. Immunol., 156, 2686-2692.
11. Enk, A. H., & Katz, S. I. (1994). Heat-stable antigen is an important costimulatory molecule on epidermal Langerhans cells. J. Immunol., 152, 3264-3270.
12. Erdmann, G., Saloga, J., Mohamadzadeh, M., Becker, D., Knop, J., & Enk, A. H. (1995). Heat-stable antigen is expressed by murine keratinocytes and delivers costimulatory signals in T-cell activation. Exp. Dermatol., 4, 291-296.
13. 9-Tetrahydrocannabinol inhibition of tumor necrosis factor-α: Suppression of post-translational events. J. Pharmacol. Exp. Ther., 267, 1558-1565.
14. Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Gibben, J. G., Ng, J. W., Kim, J., Goldberg, J. M., Hathcock, K., & Laszlo, G. (1993). Murine B7-2: An alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin-2 production. J. Exp. Med., 178, 2185-2192.
15. Germain, R. N. (1994). MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell., 76, 287-299.
16. Hynes, R. O. (1992). Integrins: Versatility, modulation, and signaling in cell adhesion. Cell, 69, 11-25.
17. Janeway, C. A. Jr, & Bottomly, K. (1994). Signals and signs for lymphocyte responses. Cell, 76, 275-285.
18. 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-κ B/Rel activation. Mol. Pharmacol., 50, 334-341.
19. Kay, R., Rosten, P. M., & Humphries, R. H. (1991). CD24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosil phosphatidylinositol membrane anchor. J. Immunol., 147, 1412-1416.
20. Kaye, P. M., Rogers, N. J., Curry, A. J., & Scott, J. C. (1994). Deficient expression of costimulatory molecules on Leishmania-infected macrophages. Eur. J. Immunol., 24, 2850-2854.
21. Kuchroo, V. K., Minami, M., Diamond, B., & Dorf, M. E. (1988). Functional analysis of cloned macrophage hybridomas. VI. Differential ability to induce immunity or suppression. J. Immunol., 141, 10-16.
22. Lanier, L. L., Gutman, G. A., Lewis, D. E., Griswold, S. T., & Warner, N. L. (1982). Monoclonal antibodies against rat Ig kappa chains. Hybridoma, 1, 125-131.
23. Ledbetter, J. A., & Herzenberg, L. A. (1979). Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev., 47, 63-90.
24. Leo, O., Foo, M., Sachs, D. H., Samelson, L. E., & Bluestone, J. A. (1987). Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. U.S.A., 84, 1374-1378.
25. Linsley, P. S., & Ledbetter, J. A. (1993). The role of CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol., 11, 191-212.
26. Liu, Y., Jones, B., Aruffo, A., Sullivan, K. M., Linsley, P. S., & Janeway, C. A. Jr (1992). Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J. Exp. Med., 175, 437-445.
27. Liu, Y., Wenger, R. H., Zhao, M., & Nielsen, P. J. (1997). Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. J. Exp. Med., 185, 251-262.
28. Lopez-Cepero, M., Friedman, M., Klein, T., & Friedman, H. (1986). Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro. J. Leukocyte Biol., 39, 679-686.
29. McCoy, K. L., Baker, P. J., Malek, T. R., & Chused, T. M. (1985). Enlargement of Lyt-2-positive T cells is associated with functional impairment and autoimmune hemolytic anemia in New Zealand Black mice. J. Immunol., 135, 2432-2437.
30. 9-Tetrahydrocannabinol modulates antigen processing by macrophages. J. Pharmacol. Exp. Ther., 273, 1216-1223.
31. McCoy, K. L., Miller, J., Jenkins, M., Ronchese, F., Germain, R. N., & Schwartz, R. H. (1989). Diminished antigen processing by endosomal acidification mutant antigen-presenting cells. J. Immunol., 143, 29-38.
32. Mondino, A., & Jenkins, M. K., (1994). Surface proteins involved in T cell costimulation. J. Leukocyte Biol., 55, 805-815.
33. 9-tetrahydrocannabinol after stimulation with concanavalin A, phytohemagglutinin, or anti-CD3 antibody. Proc. Soc. Exp. Biol. Med., 201, 165-168.
34. 9-tetrahydrocannabinol. Int. J. Immunopharmacol., 15, 423-428.
35. Powers, G. D., Faherty, D. A., Connaughton, S. E., Biondi, D. A., Godfrey, D. I., Gault, A., Chen, C. Y., & Nabavi, N. (1994). Expression and functional analysis of murine B7 delineated by a novel monoclonal antibody. Cell. Immunol., 153, 298-311.
36. Rabin, H., Hopkins, R. F., Ruscetti, F. W., Neubauer, R. H., Brown, R. L., & Kawakami, T. G. (1981). Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. J. Immunol., 127, 1852-1856.
37. Saha, B., Das, G., Vohra, H., Ganguly, N. K., & Mishra, G. C. (1994). Macrophage-T cell interaction in experimental mycobacterial infection: Selective regulation of costimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response. Eur. J. Immunol., 24, 2618-2624.
38. Samelson, L. E., Germain, R. N., & Schwartz, R. H. (1983). Monoclonal antibodies against the antigen receptor on a cloned T cell hybrid. Proc. Natl. Acad. Sci. U.S.A., 78, 6972-6976.
39. 9-Tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function. Immunopharmacol., 26, 129-137.
40. 9-tetrahydrocannabinol. J. Leukocyte Biol., 50, 423-426.
41. Springer, T. A. (1980). Cell-surface differentiation in the mouse: Characterization of "jumping" and "lineage" antigens using xenogeneic rat monoclonal antibodies. In Kennett, R. H., Bechtol, K. B. and McKearn, T. J. (Eds) Monoclonal Antibodies and Functional Cell Lines: Progress and Applications pp. 185-217. New York: Plenum Press.
42. Watzl, B., Scuderi, P., & Watson, R. R. (1991). Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1-alpha in vitro. Int. J. Immunopharmacol., 13, 1091-1097.
43. Zheng, Z.-M., Specter, S., & Friedman, H. (1992). Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages. Int. J. Immunopharmacol., 14, 1445-1452.
44. 9-Tetrahydrocannabinol enhances the secretion of interleukin 1 from endotoxin-stimulated macrophages. J. Pharmacol. Exp. Ther., 270, 1334-1339.